Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients

Overview of attention for article published in Diagnostic Pathology, June 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

AAV9-mediated gene therapy for treating mucopolysaccharidosis type I

Grant US-11890329-B2

United States of America

Gene therapy for treating mucopolysaccharidosis type I

Grant US-10973929-B2

United States of America

Compositions and methods for treating MPSI

Grant US-10792343-B2

United States of America

Compositions and methods for treating MPSI

Grant US-10137176-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.